Scalper1 News
Tuesday’s announcement that Celgene (CELG) agreed to acquire Receptos (RCPT) pleased investors in those two stocks, but for investors in Gilead Sciences (GILD), which was rumored to be interested in Receptos, it means waiting on the edges of their seats. “Literally the only question I’m getting on Gilead is, ‘When and who are they going to buy?'” said Evercore ISI analyst Mark Schoenebaum Monday in a video recorded for clients. “The stock has Scalper1 News
Scalper1 News